Matthew P. Jacobson
About Matthew P. Jacobson
Matthew P. Jacobson Title and Professional Role
Matthew P. Jacobson serves as a Venture Partner. He is a leading authority in the fields of computer-aided drug design and computational structural biology and biophysics. Additionally, he has co-founded several successful companies, including Nine Square Therapeutics, Global Blood Therapeutics, Relay Therapeutics, and Circle Pharma.
Matthew P. Jacobson Education and Expertise
Matthew P. Jacobson earned his BS from Stanford University and his PhD in physical chemistry from the Massachusetts Institute of Technology (MIT). He completed postdoctoral research at both Oxford University and Columbia University. His expertise extends across computer-aided drug design and computational structural biology and biophysics.
Matthew P. Jacobson Background and Academic Contributions
Since 2002, Matthew P. Jacobson has been a faculty member in the Department of Pharmaceutical Chemistry at UCSF, where he is currently Professor Emeritus. He has authored more than 200 research publications and several patents. His contributions to the field include widely used software in the pharmaceutical industry and extended service on the Scientific Advisory Board of Schrödinger, Inc.
Matthew P. Jacobson Notable Achievements and Awards
Matthew P. Jacobson's professional achievements include receiving the NSF CAREER Award and an Alfred P. Sloan Fellowship. He has also been recognized with several teaching awards from the UCSF School of Pharmacy. His role in co-founding Global Blood Therapeutics, which was acquired by Pfizer for $5.4 billion, demonstrates his significant impact in the pharmaceutical industry.
Matthew P. Jacobson Editorial and Advisory Roles
Matthew P. Jacobson has served on the editorial boards of eight scientific journals, including Biochemistry, PLoS Computational Biology, and Structure. He has contributed his expertise to these journals while also serving for two decades on the Scientific Advisory Board of Schrödinger, Inc., reflecting his deep involvement in advancing scientific research and applications in his field.